Electromed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Electromed, Inc. (ELMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 52.00% for the 12-month period ending 2024-06-30, per its 10-Q filed 2025-02-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2025-02-11
- Electromed, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2023-09-30 was 53.00%.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 54.00%, a 15.63% decline from fiscal 2022.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2022 was 64.00%, a 80.90% decline from fiscal 2021.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2021 was 335.00%.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2013 was 51.50%, a 26.23% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|---|
| 2024-06-30 | 52.00% 10-Q · filed 2025-02-11 | |||
| 2024-03-31 | 53.00% 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | 53.00% 10-Q · filed 2024-02-13 | |||
| 2023-09-30 | 53.00% 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 54.00% 10-K · filed 2024-08-27 | |||
| 2023-03-31 | 54.00% 10-Q · filed 2023-05-09 | |||
| 2022-06-30 | 64.00% 10-K · filed 2023-08-22 | |||
| 2022-03-31 | 64.00% 10-Q · filed 2022-05-10 | |||
| 2021-06-30 | 335.00% 10-K · filed 2022-08-23 | |||
| 2017-06-30 | 105.80% 10-Q · filed 2018-05-08 | |||
| 2013-06-30 | 51.50% 10-K · filed 2014-09-23 | |||
| 2012-06-30 | 40.80% 10-K · filed 2013-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |